The 21-Gene Recurrence Score Assay and Prediction of Chemotherapy Benefit: A Propensity Score-Matched Analysis of the SEER Database

The 21-Gene Recurrence Score Assay and Prediction of Chemotherapy Benefit: A Propensity Score-Matched Analysis of the SEER Database

Background: To evaluate the performance of the 21-gene recurrence score (RS) assay in predicting chemotherapy benefit in the Surveillance, Epidemiology, and End Results population, we aimed to assess breast cancer-specific mortality (BCSM) by chemotherapy use within each of the RS categories. Method...

Full description

Bibliographic Details
Main Authors: In Sil Choi, Jiwoong Jung, Byoung Hyuck Kim, Sohee Oh, Jongjin Kim, Jin Hyun Park, Jeong Hwan Park, Ki-Tae Hwang
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Cancers
Subjects:
breast cancer
chemotherapy
genomic assay
mortality
observational study
Online Access:https://www.mdpi.com/2072-6694/12/7/1829

Internet

https://www.mdpi.com/2072-6694/12/7/1829

Similar Items